Virtual Yoga Classes Aid Chronic Low Back Pain
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, Nov. 12, 2024 -- Virtual yoga classes may be a feasible, safe, and effective treatment option for chronic low back pain (CLBP), according to a study published online Nov. 1 in JAMA Network Open.
Hallie Tankha, Ph.D., from the Cleveland Clinic, and colleagues compared the effects of virtual yoga classes (12 consecutive weeks; 60 minutes) versus a wait-list control on CLBP intensity, back-related function, sleep quality, and pain medication use. The analysis included 140 adults (18 to 64 years of age) with CLBP.
The researchers found that at week 12, yoga now versus yoga later had greater reductions in mean pain intensity (−1.5 points) and mean Roland Morris Disability Questionnaire (RMDQ; −2.8 points) scores. The improvements in pain (mean change, −2.3 points) and RMDQ (mean change, −4.6 points) scores were sustained at 24 weeks. Yoga now participants reported 21.4 absolute percentage points less use of any analgesic medication during the past week than yoga later participants at 12 weeks and at 24 weeks (21.2 absolute percentage points). Additionally, improvements in sleep quality were greater for participants in yoga now at 12 weeks (mean change, 0.4 points) and 24 weeks (mean change, 0.4 points).
"Through reducing barriers to in-person participation, virtual yoga classes may be a feasible, safe, and effective treatment option for CLBP," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-13 12:00
Read more
- Study Characterizes Pediatric Patients Self-Presenting With Major Trauma
- Most Patients Can Keep Using GLP-1 Weight Loss Meds Before Surgeries
- Could Dad's Sperm Raise Odds for Common Complications of Pregnancy?
- When This Black Cat Crossed His Path, It Was a Lucky Day for Medicine
- Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria
- Love Bread & Pasta? Humans' Hunger for Carbs Has Ancient Roots
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions